| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |